Table 2. Treatment Practices in Patients Hospitalized With Acute Myocardial Infarction According to the Presence of Cardiogenic Shock.
Total Sample | Patients Hospitalized in 2001, 2003, and 2005 | |||||
---|---|---|---|---|---|---|
Shock Present (+) (n=905) |
Shock Absent (-) (n=12,758) |
p Value | Shock Present (+) (n=173) |
Shock Absent (-) (n=3,126) |
p Value | |
Medications (%) | ||||||
Angiotensin converting enzyme inhibitors/angiotensin receptor blockers**** | 48.6 | 47.9 | 0.74 | 62.4 | 68.1 | 0.13 |
Aspirin | 52.2 | 65.7 | <.001 | 90.2 | 91.4 | 0.60 |
Beta blockers | 40.2 | 63.4 | <.001 | 76.9 | 90.2 | <0.001 |
Calcium channel blockers** | 26.0 | 38.2 | <.001 | 20.2 | 25.4 | 0.12 |
Lipid lowering agents*** | 20.2 | 31.0 | <.001 | 56.7 | 66.8 | <0.01 |
Thrombolytics*** | 18.8 | 15.9 | 0.05 | 6.4 | 5.3 | 0.55 |
Procedures (%) | ||||||
Cardiac catheterization | 35.8 | 30.7 | <.001 | 74.0 | 55.5 | <0.001 |
Coronary artery bypass graft surgery* | 6.9 | 3.8 | <.001 | 7.5 | 6.0 | 0.44 |
Percutaneous coronary intervention*** | 28.8 | 19.3 | <.001 | 57.8 | 38.6 | <0.001 |
Intraortic balloon counterpulsation | 29.7 | 2.0 | <.001 | 54.3 | 3.5 | <0.001 |
81-05 only
84-05 only
86-05 only
90-05 only